# Johnson & Johnson (JNJ) FY2025 Q1 P&L / Income Statement

- Company: Johnson & Johnson (JNJ)
- Period: 2024-12-30 to 2025-03-30
- Filing: Q1 FY2025 10-Q, filed 2025-04-23, accession number 0000200406-25-000119
- Page: https://plicit.ai/financials/jnj/fy2025-q1-income-statement
- Chart image: https://plicit.ai/charts/jnj-fy2025-q1-income-statement-sankey.png

## Chart details: Revenue by Business Segment by Subsegment

Income statement for 2024-12-30 through 2025-03-30. View: Segments by Subsegments. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 21,893,000,000 US dollars
- **Cost of products sold**: 7,357,000,000 US dollars
- **Gross profit**: 14,536,000,000 US dollars
- **Operating expenses (calculated)**: 8,354,000,000 US dollars
- **Operating profit (calculated)**: 6,182,000,000 US dollars
- **Other income (expense), net (calculated)**: 7,449,000,000 US dollars
- **Earnings before provision for taxes on income**: 13,631,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 2,632,000,000 US dollars
- **Net earnings**: 10,999,000,000 US dollars
- **Innovative Medicine - Cardiovascular / Metabolism / Other**: 1,013,000,000 US dollars
- **Innovative Medicine - Immunology**: 3,707,000,000 US dollars
- **Innovative Medicine - Infectious Diseases**: 802,000,000 US dollars
- **Innovative Medicine - Neuroscience**: 1,647,000,000 US dollars
- **Innovative Medicine - Oncology**: 5,678,000,000 US dollars
- **Innovative Medicine - Pulmonary Hypertension**: 1,025,000,000 US dollars
- **MedTech - Abiomed**: 420,000,000 US dollars
- **MedTech - Cardiovascular**: 2,103,000,000 US dollars
- **MedTech - Electrophysiology**: 1,323,000,000 US dollars
- **MedTech - Orthopaedics**: 2,241,000,000 US dollars
- **MedTech - Other Cardiovascular**: 103,000,000 US dollars
- **MedTech - Shockwave**: 258,000,000 US dollars
- **MedTech - Surgery**: 2,396,000,000 US dollars
- **MedTech - Vision**: 1,279,000,000 US dollars
- **Research and development expense**: 3,225,000,000 US dollars
- **Restructuring (Note 12)**: 17,000,000 US dollars
- **Selling, marketing and administrative expenses**: 5,112,000,000 US dollars
- **Revenue before reconciliation (calculated)**: 23,995,000,000 US dollars. Sum of the reported revenue categories before the separately reported reconciliation.
- **Components above reported revenue (calculated)**: negative 2,102,000,000 US dollars. The disclosed components add up to more than reported revenue; this is the difference, calculated, not a reported item.

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.
- Reported revenue categories plus the separately reported signed reconciliation equals consolidated revenue.

## Chart details: Revenue by Geography (4 categories)

- Page: https://plicit.ai/financials/jnj/fy2025-q1-income-statement/revenue-by-geography-4-categories
- Chart image: https://plicit.ai/charts/jnj-fy2025-q1-revenue-by-geography-4-categories-sankey.png

Income statement for 2024-12-30 through 2025-03-30. View: Geography (4 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 21,893,000,000 US dollars
- **Cost of products sold**: 7,357,000,000 US dollars
- **Gross profit**: 14,536,000,000 US dollars
- **Operating expenses (calculated)**: 8,354,000,000 US dollars
- **Operating profit (calculated)**: 6,182,000,000 US dollars
- **Other income (expense), net (calculated)**: 7,449,000,000 US dollars
- **Earnings before provision for taxes on income**: 13,631,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 2,632,000,000 US dollars
- **Net earnings**: 10,999,000,000 US dollars
- **UNITED STATES**: 12,305,000,000 US dollars
- **Europe**: 5,110,000,000 US dollars
- **Western Hemisphere, excluding U.S.**: 1,167,000,000 US dollars
- **Asia-Pacific, Africa**: 3,311,000,000 US dollars
- **Research and development expense**: 3,225,000,000 US dollars
- **Restructuring (Note 12)**: 17,000,000 US dollars
- **Selling, marketing and administrative expenses**: 5,112,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment

- Page: https://plicit.ai/financials/jnj/fy2025-q1-income-statement/revenue-by-business-segment
- Chart image: https://plicit.ai/charts/jnj-fy2025-q1-revenue-by-business-segment-sankey.png

Income statement for 2024-12-30 through 2025-03-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 21,893,000,000 US dollars
- **Cost of products sold**: 7,357,000,000 US dollars
- **Gross profit**: 14,536,000,000 US dollars
- **Operating expenses (calculated)**: 8,354,000,000 US dollars
- **Operating profit (calculated)**: 6,182,000,000 US dollars
- **Other income (expense), net (calculated)**: 7,449,000,000 US dollars
- **Earnings before provision for taxes on income**: 13,631,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 2,632,000,000 US dollars
- **Net earnings**: 10,999,000,000 US dollars
- **Innovative Medicine**: 13,873,000,000 US dollars
- **MedTech**: 8,020,000,000 US dollars
- **Research and development expense**: 3,225,000,000 US dollars
- **Restructuring (Note 12)**: 17,000,000 US dollars
- **Selling, marketing and administrative expenses**: 5,112,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Business Segment by Geography

- Page: https://plicit.ai/financials/jnj/fy2025-q1-income-statement/revenue-by-business-segment-by-geography
- Chart image: https://plicit.ai/charts/jnj-fy2025-q1-revenue-by-business-segment-by-geography-sankey.png

Income statement for 2024-12-30 through 2025-03-30. View: Segments by Geographical. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 21,893,000,000 US dollars
- **Cost of products sold**: 7,357,000,000 US dollars
- **Gross profit**: 14,536,000,000 US dollars
- **Operating expenses (calculated)**: 8,354,000,000 US dollars
- **Operating profit (calculated)**: 6,182,000,000 US dollars
- **Other income (expense), net (calculated)**: 7,449,000,000 US dollars
- **Earnings before provision for taxes on income**: 13,631,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 2,632,000,000 US dollars
- **Net earnings**: 10,999,000,000 US dollars
- **Innovative Medicine - UNITED STATES**: 8,092,000,000 US dollars
- **Innovative Medicine - International**: 5,781,000,000 US dollars
- **MedTech - UNITED STATES**: 4,213,000,000 US dollars
- **MedTech - International**: 3,807,000,000 US dollars
- **Research and development expense**: 3,225,000,000 US dollars
- **Restructuring (Note 12)**: 17,000,000 US dollars
- **Selling, marketing and administrative expenses**: 5,112,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.

## Chart details: Revenue by Geography (2 categories)

- Page: https://plicit.ai/financials/jnj/fy2025-q1-income-statement/revenue-by-geography-2-categories
- Chart image: https://plicit.ai/charts/jnj-fy2025-q1-revenue-by-geography-2-categories-sankey.png

Income statement for 2024-12-30 through 2025-03-30. View: Geography (2 categories). Revenue uses this breakdown; costs and expenses retain the consolidated categories.

- **Sales to customers (Note 9)**: 21,893,000,000 US dollars
- **Cost of products sold**: 7,357,000,000 US dollars
- **Gross profit**: 14,536,000,000 US dollars
- **Operating expenses (calculated)**: 8,354,000,000 US dollars
- **Operating profit (calculated)**: 6,182,000,000 US dollars
- **Other income (expense), net (calculated)**: 7,449,000,000 US dollars
- **Earnings before provision for taxes on income**: 13,631,000,000 US dollars
- **Provision for taxes on income (Note 5)**: 2,632,000,000 US dollars
- **Net earnings**: 10,999,000,000 US dollars
- **UNITED STATES**: 12,305,000,000 US dollars
- **International**: 9,588,000,000 US dollars
- **Research and development expense**: 3,225,000,000 US dollars
- **Restructuring (Note 12)**: 17,000,000 US dollars
- **Selling, marketing and administrative expenses**: 5,112,000,000 US dollars

### Chart connections

- Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
- Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit equals net income.